News Releases
Viewing Category: Onglyza
-
MONTREAL, QC, and TORONTO, ON - November 12, 2009
Health Canada Approves New Treatment for Adults With Type 2 Diabetes
ONGLYZA™ (saxagliptin) approval coincides with new research that shows 91 per cent of Canadians with diabetes are drifting in the management of their disease
